BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Shanghai Fosun to Take Control of Taiwan’s Henlix for $98M

  Fosun Pharma will pay up to $98M to buy the 69% of Henlix Biotech it doesn’t already own.

  November 3, 2017

   · 

  1 min read
• 

  Policy

  SEC Charges Osiris, Four Former Execs With Accounting Fraud

  Osiris has settled a case of accounting fraud with the U.S. SEC, but four former company execs will face charges for the alleged financial misreporting.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Torrent Pharma Coughs Up $558M for Unichem’s India Biz

  The acquisition is expected to close by the end of 2017.

  November 3, 2017

   · 

  1 min read
• 

  Business

  Varian Inks $50M Multi-Year Project Deal

  The company secured a deal to equip Rigshospitalet and Herlev Hospital with modern treatment systems over the next few years.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Mysterious Moderna Hints at Its IPO Timeline

  Moderna CEO said the company was not likely to float its initial public offering until the company has solid data on its lead mRNA treatment.

  November 3, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Fitbit CEO Details Ambitions for Diabetes Management

  The company has been especially active in diabetes management with collaboration partners that include medical device giant Medtronic and DexCom.

  November 3, 2017

   · 

  1 min read
• 

  Biotech Bay

  How Gilead Lost $7.8B in October Alone

  Gilead Sciences’ third-quarter financial results were dismal, to say the least.

  November 3, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  This is the Precision Medicine Biotech That’s Revolutionizing Cancer Treatment

  Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.

  November 3, 2017

   · 

  1 min read
• 

  Pharm Country

  Defective EpiPens Cited in 7 Deaths This Year, FDA Files Reveal

  The FDA has also received 228 reports of EpiPen failures and at least 35 people were hospitalized as a result of those failures.

  November 3, 2017

   · 

  1 min read
• Business

  Hill-Rom Highlights Long-Term Strategic And Financial Objectives

  Hill-Rom expects reported revenue growth (on a constant currency basis) to be in the 3 to 4 percent range on a compound annual basis from 2017 through 2020.

  November 3, 2017

   · 

  8 min read